GAO Xian-shu,ZHOU Zhi-guo,QIAO Xue-ying,et al.A preliminary report of 7-day continuous accelerated irradiation in patients with esophageal carcinoma[J].Chinese Journal of Radiological Medicine and Protection,2005,25(1):59-62
A preliminary report of 7-day continuous accelerated irradiation in patients with esophageal carcinoma
Received:June 26, 2004  
DOI:
KeyWords:Esophageal cancer  Radiotherapy  Accelerated fractionation  Toxicity  Overall treatment time
FundProject:
Author NameAffiliationE-mail
GAO Xian-shu Department of Radiation Oncology, 4th Hospital of Hebei Medical University, Shijiazhuang 050011, China gaoxs@heinfo.net 
ZHOU Zhi-guo Department of Radiation Oncology, 4th Hospital of Hebei Medical University, Shijiazhuang 050011, China  
QIAO Xue-ying Department of Radiation Oncology, 4th Hospital of Hebei Medical University, Shijiazhuang 050011, China  
杨香然 Department of Radiation Oncology, 4th Hospital of Hebei Medical University, Shijiazhuang 050011, China  
张钧 Department of Radiation Oncology, 4th Hospital of Hebei Medical University, Shijiazhuang 050011, China  
万钧 Department of Radiation Oncology, 4th Hospital of Hebei Medical University, Shijiazhuang 050011, China  
Hits: 3654
Download times: 2174
Abstract::
      Objective Toxicity of the 7-day continuous accelerated irradiation schedule (CAIR) was evaluated and compared with the late course accelerated hyperfractionation radiotherapy schedule (LCAF) for esophageal carcinoma in a randomized trial. Methods Fifty-seven patients with squamous cell carcinoma of esophagus were randomly enrolled into two groups: 29 to the CAIR group and 28 to the LCAF group. In CAIR group the dose per fraction of 2.0 Gy was given once a day at 24 h intervals and the overall treatment time was 4.2 weeks (30 days). The patients in the LCAF group received conventional fractionation radiotherapy, at 2 Gy/fraction, to a dose of 30 Gy in 15 fractions during 3 weeks, followed by accelerated fractionation radiotherapy, b.i.d., at 1.5 Gy/fraction, with a minimal interval of 6 h between fractions, and the overall treatment time was 5 weeks. The total dose was 60 Gy in both groups. Results More serious acute esophagitis was observed in CAIR group than that in LCAF group, and the incidences of grade Ⅲ esophagitis were 31.0% and 14.3%, respectively. The late effect was not more frequent in CAIR group than in the LCAF group, the incidences of grade Ⅴ esophageal late effect were 10.3% and 7.1%, and the 1-year survival rates were 66.14% and 64.72%,respectively in CAIR group and LCAF group. Conclusion Although the higher incidences of severe acute reactions were observed in CAIR group, the patients could tolerate the effects and complete this treatment.
HTML  View Full Text  View/Add Comment  Download reader
Close

Copyright©    Editorial Office of Chinese Journal of Radiological Medicine and Protection    

Beijing ICP No. 05020547 -2

Address: 2 Xinkang Street, Dewai, Beijing 100088, China

Telephone:010-62389620; Email:cjrmp@cjrmp.sina.net

Technical Support:Beijing E-tiller CO.,LTD.

Visitors:12028915  On-line:0

v
Scan QR Code
&et=C6BEF307885BECF1318D3ED712BE3932BB7155F46B3BDA49A4A04CDBF86A3E165DBCB4D757D496F80BD15AADDB64723EEB41AA7A4860ABA4FFC663EF3F1C24315CF0D322419374A31BD276A9B17599E08B401D96CED5D9BFC7FEDA5045CBFE2FE7D7DCB6B503ED96&pcid=A9DB1C13C87CE289EA38239A9433C9DC&cid=D4D466D60FDC1A5A&jid=5E4353813E091AB841B02B880782B82C&yid=2DD7160C83D0ACED&aid=C46985881A4D4DBF&vid=&iid=CA4FD0336C81A37A&sid=6AC2A205FBB0EF23&eid=95D537AC89B28832&fileno=20050123&flag=1&is_more=0"> var my_pcid="A9DB1C13C87CE289EA38239A9433C9DC"; var my_cid="D4D466D60FDC1A5A"; var my_jid="5E4353813E091AB841B02B880782B82C"; var my_yid="2DD7160C83D0ACED"; var my_aid="C46985881A4D4DBF";